C12N 2501/20
Cytokines
Official title: Cytokines; Chemokines
C12N2501/20 (Cytokines) appears on 2,334 US grants and 5,049 published applications in this corpus.
Search patents in C12N- Granted patents
- 2,334
- Published applications
- 5,049
- Assignees
- 1,879
- Inventors
- 8,224
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 6 | 0 |
| 1993 | 7 | 0 |
| 1994 | 8 | 0 |
| 1995 | 16 | 0 |
| 1996 | 9 | 0 |
| 1997 | 34 | 0 |
| 1998 | 47 | 0 |
| 1999 | 35 | 0 |
| 2000 | 37 | 0 |
| 2001 | 38 | 21 |
| 2002 | 28 | 85 |
| 2003 | 37 | 98 |
| 2004 | 29 | 109 |
| 2005 | 31 | 121 |
| 2006 | 36 | 115 |
| 2007 | 20 | 89 |
| 2008 | 37 | 90 |
| 2009 | 41 | 125 |
| 2010 | 61 | 148 |
| 2011 | 46 | 126 |
| 2012 | 73 | 120 |
| 2013 | 60 | 125 |
| 2014 | 80 | 123 |
| 2015 | 102 | 157 |
| 2016 | 92 | 163 |
| 2017 | 100 | 191 |
| 2018 | 102 | 207 |
| 2019 | 107 | 265 |
| 2020 | 126 | 291 |
| 2021 | 149 | 393 |
| 2022 | 116 | 419 |
| 2023 | 128 | 386 |
| 2024 | 178 | 437 |
| 2025 | 180 | 382 |
| 2026 | 132 | 263 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2501/23Interleukins [il]Indexing code1,915
- C12N 2501/22Colony stimulating factorsIndexing code519
- C12N 2501/26Flt-3 ligandIndexing code291
- C12N 2501/24Interferons [ifn]Indexing code288
- C12N 2501/25Tumour necrosing factors [tnf]Indexing code259
- C12N 2501/21ChemokinesIndexing code146
- C12N 2501/237Oncostatin m [osm]Indexing code57
Recent patents
- Methods of culturing quiescent hematopoietic stem cells and treatment methods6 Oct 2026US 12,753,389 B2Icahn School of Medicine at Mount Sinai
- Composition for enhancing reprogramming efficiency from somatic cell to induced pluripotent stem cell, comprising mTOR activator, and method for enhancing reprogramming efficiency by using same6 Oct 2026US 12,753,394 B2Korea University Research and Business Foundation
- Monoclonal antibody drug sensitivity in multiple myeloma patients6 Oct 2026US 12,754,180 B2The Regents of the University of Colorado, a body corporate
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Compositions and methods for providing hematopoietic function without HLA matching22 Sep 2026US 12,741,001 B2Fred Hutchinson Cancer Center
- Methods and compositions related to platelet releasate and platelet-rich fibrin8 Oct 2026US 2026/0306546 A1Biobridge Global
- Nk cell compositions and preparations for immunotherapy and methods for their production8 Oct 2026US 2026/0308226 A1Deverra Therpaeutics Inc.
- Metabolically enhanced vd1 t cells and uses thereof8 Oct 2026US 2026/0308518 A1
- Cd4+ cytotoxic t cells and methods of use thereof8 Oct 2026US 2026/0308522 A1Dana-Farber Cancer Institute, Inc.
- Composition for inducing dendritic cell differentiation, comprising metal-organic framework, and use thereof8 Oct 2026US 2026/0308523 A1Mediark Inc.
Most cited
By later US patents
- Human mesenchymal stem cells813US 5,486,359 AOsiris Therapeutics, Inc. · 1996
- Method for treating connective tissue disorders633US 5,226,914 A1993
- Handheld electromechanical surgical system627US 10,932,784 B2Covidien LP · 2021
- Connective tissue regeneration using human mesenchymal stem cell preparations470US 5,811,094 AOsiris Therapeutics, Inc. · 1998
- Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells444US 5,197,985 A1993